Massive french study to test if RSV antibody shot stops childhood wheezing
NCT ID NCT07317141
First seen Jan 06, 2026 · Last updated May 16, 2026 · Updated 10 times
Summary
This study looks at whether giving babies a medicine called nirsevimab early in life can prevent wheezing and asthma-like symptoms as they grow up. Researchers will compare 218,000 children in France who received the shot with those who did not, using health records to track hospitalizations for wheezing. The goal is to see if preventing RSV infections in infancy reduces long-term breathing problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA CHILDHOOD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospices Civils de Lyon - Hôpital Femme Mère Enfant
Bron, 69677, France
Conditions
Explore the condition pages connected to this study.